Loading clinical trials...
Loading clinical trials...
Injectable DMAU for Male Contraception: Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of Single IM or SC DMAU Injection Dose Escalation Study in Healthy Male Volunteers
Conditions
Interventions
Dimethandrolone Undecanoate
Placebo
Locations
2
United States
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Torrance, California, United States
University of Washington Medical Center & Health Sciences
Seattle, Washington, United States
Start Date
February 15, 2017
Primary Completion Date
November 7, 2024
Completion Date
April 29, 2025
Last Updated
October 31, 2025
NCT06672016
NCT07393334
NCT05825781
NCT02754687
NCT03455075
NCT07222228
Lead Sponsor
Kimberly Myer
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions